Sponsor content
330 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI (DFP-EvoCap).
-
Australian public assessment report (AusPar)Kavigale (sipavibart) has been approved for the pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who are immunocompromised due to a medical condition or receipt of immunosuppressive medications or treatments.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DAPAGLIFLOZIN AZN dapagliflozin (as propanediol monohydrate) 10 mg film-coated tablet blister pack.
-
Feb-2026Prescription medicine evaluationActive ingredient: datopotamab deruxtecan.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUMIST influenza virus vaccine 10,000,000 FFU/strain (0.2mL) nasal spray applicator.
-
Designation or determinationPriority review
-
Jan-2026Prescription medicine evaluationActive ingredient: trastuzumab deruxtecan.
-
Prescription medicine registrationActive ingredients: trastuzumab deruxtecan.
-
Prescription medicine registrationActive ingredients: Influenza virus.